Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
What Aspects Will Give Humira Biosimilars The Edge In 2023?
Vizient Report Examines Views Of Pharmacy Executives And Professionals
Sep 29 2022
•
By
David Wallace
As US Humira biosimilars approach launch, which are best positioned? • Source: Shutterstock
More from Biosimilars
More from Products